PCI Biotech Holding ASA (FRA:4QG)
Germany flag Germany · Delayed Price · Currency is EUR
0.0170
-0.0002 (-1.16%)
At close: Jan 30, 2026

PCI Biotech Holding ASA Balance Sheet

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
13.6226.6940.856.6116.12187.97
Cash & Short-Term Investments
13.6226.6940.856.6116.12187.97
Cash Growth
-55.41%-34.57%-27.91%-51.26%-38.22%-28.01%
Other Receivables
4.053.782.576.165.15.99
Receivables
4.053.782.576.165.15.99
Prepaid Expenses
-0.06--7.17.18
Restricted Cash
-0.380.39---
Other Current Assets
---0---
Total Current Assets
17.6730.9143.7562.76128.32201.13
Property, Plant & Equipment
0.860.310.30.727.667.99
Other Long-Term Assets
-0--0-0
Total Assets
18.5231.2244.0563.48135.98209.12
Accounts Payable
0.481.720.710.53.755.19
Accrued Expenses
-5.713.944.8215.9313.98
Current Portion of Leases
0.280.340.320.440.630.67
Other Current Liabilities
5.25-0--00.61-0
Total Current Liabilities
6.017.764.975.7520.9119.85
Long-Term Leases
---0.331.28-
Other Long-Term Liabilities
--0.03--0.03
Total Liabilities
6.017.765.016.0822.1919.88
Common Stock
1.121.121.12111.98111.98111.98
Additional Paid-In Capital
-22.3337.92-450.46450.46
Retained Earnings
----54.58-448.65-373.2
Comprehensive Income & Other
11.4000-0-
Shareholders' Equity
12.5223.4539.0457.4113.79189.24
Total Liabilities & Equity
18.5231.2244.0563.48135.98209.12
Total Debt
0.280.340.320.771.910.67
Net Cash (Debt)
13.3426.3640.4855.83114.21187.29
Net Cash Growth
-55.64%-34.89%-27.49%-51.12%-39.02%-27.94%
Net Cash Per Share
0.360.711.081.503.065.02
Filing Date Shares Outstanding
37.3337.3337.3337.3337.3337.33
Total Common Shares Outstanding
37.3337.3337.3337.3337.3337.33
Working Capital
11.6623.1438.7857.01107.41181.28
Book Value Per Share
0.340.631.051.543.055.07
Tangible Book Value
12.5223.4539.0457.4113.79189.24
Tangible Book Value Per Share
0.340.631.051.543.055.07
Machinery
---10109.66
Source: S&P Global Market Intelligence. Standard template. Financial Sources.